hypericin has been researched along with Cancer of Ovary in 6 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " Nevertheless, both formulations yielded severe photocytotoxicity in SK-OV-3 cells in a therapeutic dosage range." | 1.51 | Photodynamic therapy - hypericin tetraether liposome conjugates and their antitumor and antiangiogenic activity. ( Bakowsky, U; Brüßler, J; Duse, L; Goergen, N; Jedelska, J; Pinnapireddy, SR; Plenagl, N; Seitz, BS, 2019) |
| "Moreover, we found that a subset of cancer patients of various cancer-types indeed possessed CALRlow or CRTlow-tumours." | 1.42 | Resistance to anticancer vaccination effect is controlled by a cancer cell-autonomous phenotype that disrupts immunogenic phagocytic removal. ( Agostinis, P; de Witte, P; Elsen, S; Garg, AD; Krysko, DV; Vandenabeele, P, 2015) |
| "The high recurrence and lethality of ovarian cancer at advanced stages is problematic, especially due to the development of numerous micrometastases scattered throughout the abdominal cavity." | 1.35 | Benefits of nanoencapsulation for the hypercin-mediated photodetection of ovarian micrometastases. ( Delie, F; Gurny, R; Lange, N; Zeisser-Labouèbe, M, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Plenagl, N | 1 |
| Duse, L | 1 |
| Seitz, BS | 1 |
| Goergen, N | 1 |
| Pinnapireddy, SR | 1 |
| Jedelska, J | 1 |
| Brüßler, J | 1 |
| Bakowsky, U | 1 |
| Garg, AD | 1 |
| Elsen, S | 1 |
| Krysko, DV | 1 |
| Vandenabeele, P | 1 |
| de Witte, P | 1 |
| Agostinis, P | 1 |
| Zeisser-Labouèbe, M | 4 |
| Delie, F | 4 |
| Gurny, R | 4 |
| Lange, N | 4 |
| Mattiuzzo, M | 1 |
6 other studies available for hypericin and Cancer of Ovary
| Article | Year |
|---|---|
Photodynamic therapy - hypericin tetraether liposome conjugates and their antitumor and antiangiogenic activity.
Topics: Angiogenesis Inhibitors; Animals; Anthracenes; Antineoplastic Agents; Cell Line, Tumor; Chickens; Ch | 2019 |
Resistance to anticancer vaccination effect is controlled by a cancer cell-autonomous phenotype that disrupts immunogenic phagocytic removal.
Topics: Animals; Anthracenes; Antineoplastic Agents; Apoptosis; Biomarkers, Tumor; Calreticulin; Cancer Vacc | 2015 |
Benefits of nanoencapsulation for the hypercin-mediated photodetection of ovarian micrometastases.
Topics: Animals; Anthracenes; Disease Models, Animal; Drug Delivery Systems; Endoscopy; Female; Fluorescence | 2009 |
Screening of nanoparticulate delivery systems for the photodetection of cancer in a simple and cost-effective model.
Topics: Animals; Anthracenes; Cell Line, Tumor; Chick Embryo; Chickens; Chorioallantoic Membrane; Early Dete | 2009 |
Quenching-induced deactivation of photosensitizer by nanoencapsulation to improve phototherapy of cancer.
Topics: Anthracenes; Cell Line, Tumor; Drug Delivery Systems; Female; Fluorescence; Humans; Nanoparticles; O | 2009 |
Hypericin-loaded nanoparticles for the photodynamic treatment of ovarian cancer.
Topics: Animals; Anthracenes; Cell Line, Tumor; Chemistry, Pharmaceutical; Drug Delivery Systems; Female; Hu | 2006 |